Related Experiment Video
Updated: Aug 7, 2026
Navigating MARRVEL, a Web-Based Tool that Integrates Human Genomics and Model Organism Genetics Information
Published on: August 15, 2019
Clinical spectrum of pediatric patients carrying heterozygous MEFV gene variants
Elif Erorhan1, Pınar Özge Avar Aydın1, Fatma Aydın1
1Department of Pediatrics, Division of Pediatric Rheumatology, Ankara University School of Medicine, Ankara, 06590, Turkey.
Abstract:
The MEditerranean FeVer (MEFV) gene is a critical regulator of the innate immune response. The prototypical disease related to the MEFV gene is familial Mediterranean fever (FMF). Heterozygous MEFV gene variants have increasingly been reported in association with a wide range of inflammatory disorders besides FMF. The aim of this study was to evaluate the diagnostic spectrum and clinical and demographic findings of patients carrying heterozygous MEFV variants. This retrospective study included pediatric patients carrying heterozygous MEFV variants who were followed up at our center between January 2012 and January 2025. Diagnosis, demographics, and clinical manifestations were reviewed. A total of 270 patients with a median age of 7 years were identified. The diagnoses of the study population included FMF (67%), IgA vasculitis (7%), PFAPA syndrome (6%), inflammatory bowel disease (3%), juvenile idiopathic arthritis (3%), chronic nonbacterial osteomyelitis (2%), Behçet's disease (1%), and other vasculitides (1%). Fourteen percent of the patients were asymptomatic carriers. During follow-up, 22 of the 74 patients (30%) initially diagnosed with other inflammatory conditions later developed clinical features consistent with FMF. Colchicine therapy was initiated not only for typical attacks of FMF but also for selected indications in other inflammatory diseases.
Conclusion:
Heterozygous MEFV variants have been reported to be associated with various inflammatory diseases besides FMF. Long-term follow-up is essential, as some patients may later develop FMF. MEFV gene testing should be considered in other inflammatory diseases with severe or atypical manifestations, particularly in populations where FMF is highly prevalent.
What Is Known:
• Heterozygous MEFV variants have been associated with FMF and several inflammatory diseases.
What Is New:
• This large pediatric cohort demonstrates that heterozygous MEFV variants may be encountered across a broad spectrum of inflammatory diseases, and some patients initially diagnosed with other conditions may subsequently develop FMF during follow-up.
Insights
Heterozygous MEFV variants are linked to various inflammatory diseases beyond familial Mediterranean fever (FMF). Some patients initially diagnosed with other conditions may later develop FMF, necessitating long-term monitoring.
Area of Science:
- Immunology
- Genetics
- Pediatrics
Background:
- Heterozygous variants in the Mediterranean Fever (MEFV) gene are associated with familial Mediterranean fever (FMF) and other inflammatory conditions.
- Previous research indicates a link between heterozygous MEFV variants and diverse inflammatory diseases.
Purpose of the Study:
- To investigate the diagnostic spectrum of heterozygous MEFV variants in pediatric patients.
- To analyze the clinical and demographic characteristics of these patients.
Main Methods:
- A retrospective study of pediatric patients with heterozygous MEFV variants followed between January 2012 and January 2025.
- Review of patient diagnoses, demographics, and clinical manifestations.
Main Results:
- 270 pediatric patients with a median age of 7 years were identified.
- Diagnoses included FMF (67%), IgA vasculitis (7%), PFAPA syndrome (6%), and others; 14% were asymptomatic carriers.
- 30% of patients initially diagnosed with other inflammatory conditions later developed FMF.
Conclusions:
- Heterozygous MEFV variants are associated with a wide array of inflammatory diseases.
- Long-term follow-up is crucial as some patients may develop FMF later.
- MEFV gene testing is recommended for inflammatory diseases with severe/atypical features, especially in FMF-prevalent populations.
Related Concept Videos
02:41Lethal Alleles
Lucien Cuénot discovered lethal alleles in 1905 while studying the inheritance of coat color in mice. The agouti gene is responsible for the color of the coat in mice. This gene codes for an agouti-signaling protein, which is responsible for melanin distribution in mammals. The wild-type allele gives rise to gray-brown coat color in mice, while the mutant allele gives rise to yellow coat color. In addition to coat color, the agouti gene is associated with the yellow...
01:49Multiple Allele Traits
01:43Sex-linked Disorders
01:33Pleiotropy
01:43Incomplete Dominance
01:11Genetic Lingo